Eli Lilly and Company

Senior Director -Construction Capital Procurement

United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Construction, Industrial & ManufacturingIndustries

Requirements

Candidates should possess a Bachelor’s degree in a relevant field, along with a minimum of 10 years of experience in construction capital procurement, including experience leading and developing procurement teams for mega industrial capital projects. Strong knowledge of the construction capital procurement lifecycle is essential, as is experience with supplier selection, contract negotiations, and supplier relationship management. Demonstrated expertise in FRAP compliance is required.

Responsibilities

The Senior Director - Construction Capital Procurement will lead procurement for engineering, automation, equipment, and construction categories, developing sourcing strategies, managing supplier selection, negotiating contracts, and maintaining supplier relationships. They will oversee sourcing efforts at new greenfield sites, ensuring a cost-effective and resilient supply chain, and collaborate with business clients to understand their strategies and key success levers. The role involves providing procurement expertise, prioritizing projects, and aligning business activities to support work-life balance, while also ensuring compliance and performance across all transactions.

Skills

Construction procurement lifecycle
Team leadership and development
Mega industrial capital projects support
Negotiation
Contract management
Supplier relationship management
Cross-category collaboration
FRAP compliance

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Key Metrics

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI